These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10931100)

  • 1. Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study.
    Schmiegelow M; Lassen S; Poulsen HS; Feldt-Rasmussen U; Schmiegelow K; Hertz H; Müller J
    Clin Endocrinol (Oxf); 2000 Aug; 53(2):191-7. PubMed ID: 10931100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetry and growth hormone deficiency following cranial irradiation of childhood brain tumors.
    Schmiegelow M; Lassen S; Weber L; Poulsen HS; Hertz H; Müller J
    Med Pediatr Oncol; 1999 Dec; 33(6):564-71. PubMed ID: 10573581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor.
    Schmiegelow M; Feldt-Rasmussen U; Rasmussen AK; Poulsen HS; Müller J
    J Clin Endocrinol Metab; 2003 Jan; 88(1):136-40. PubMed ID: 12519842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of growth hormone neurosecretory disturbance after cranial irradiation for childhood brain tumours: a prospective study.
    Spoudeas HA; Hindmarsh PC; Matthews DR; Brook CG
    J Endocrinol; 1996 Aug; 150(2):329-42. PubMed ID: 8869599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
    Ham JN; Ginsberg JP; Hendell CD; Moshang T
    Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor.
    Schmiegelow M; Feldt-Rasmussen U; Rasmussen AK; Lange M; Poulsen HS; Müller J
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3149-54. PubMed ID: 12843158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhood brain tumors.
    Schmiegelow M; Lassen S; Poulsen HS; Feldt-Rasmussen U; Schmiegelow K; Hertz H; Müller J
    Horm Res; 2000; 54(2):53-9. PubMed ID: 11251367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours.
    Weinzimer SA; Homan SA; Ferry RJ; Moshang T
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):339-45. PubMed ID: 10469014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between the growth hormone and insulin-like growth factor axis in long-term survivors of childhood brain tumours.
    Achermann JC; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):639-45. PubMed ID: 10197080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadal status in male survivors following childhood brain tumors.
    Schmiegelow M; Lassen S; Poulsen HS; Schmiegelow K; Hertz H; Andersson AM; Skakkebaek NE; Müller J
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2446-52. PubMed ID: 11397837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease.
    Toogood AA; Jones J; O'Neill PA; Thorner MO; Shalet SM
    Clin Endocrinol (Oxf); 1998 May; 48(5):569-76. PubMed ID: 9666868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?
    Cianfarani S; Tondinelli T; Spadoni GL; Scirè G; Boemi S; Boscherini B
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):161-7. PubMed ID: 12153594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences on quality of life in GH deficient adults and their effect on response to treatment.
    Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low sensitivity of IGF-I, IGFBP-3 and urinary GH in the diagnosis of growth hormone insufficiency in slowly-growing short-statured boys. Grupo Español de Estudio de la Talla Baja].
    Audí L; Antonia Llopis M; Luisa Granada M; Hermoso F; del Valle J; Dolores Rodríguez-Arnao M; Bel J; Luzuriaga C; Gallego E; Marín F;
    Med Clin (Barc); 2001 Jan; 116(1):6-11. PubMed ID: 11181253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3.
    Juul A; Skakkebaek NE
    J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency.
    van Doorn J; Ringeling AM; Rikken B; van Buul-Offers SC
    Horm Res; 2001; 55(3):147-54. PubMed ID: 11549877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation dose-volume effects on growth hormone secretion.
    Merchant TE; Goloubeva O; Pritchard DL; Gaber MW; Xiong X; Danish RK; Lustig RH
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1264-70. PubMed ID: 11955738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.